• Home
  • About Us
  • Contact
  • Subscribe
  • Your Account
No Result
View All Result
Monday, March 20, 2023
Alternatives Watch
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
  • Subscribe
  • Log In
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
  • Subscribe
  • Log In
No Result
View All Result
Alternatives Watch
No Result
View All Result

Patient Square closes inaugural fund at $3.9bn

Susan BarretobySusan Barreto
February 1, 2023
in Manager News, Open Access, Private Equity
Patient Square closes inaugural fund at $3.9bn

Jim Momtazee, managing partner of Patient Square (provided)

ShareTweetShareSendSend

Patient Square Capital held the final close of its Patient Square Equity Partners fund with $3.9 billion in total capital commitments.

For the healthcare-focused private equity firm, the offering handily surpassed its target and is sizable in the healthcare space.

The investment focus for the Menlo Park, California firm is broadly across the healthcare industry, which includes development-stage therapeutics, commercial-stage pharmaceuticals, medical devices, diagnostics and life science tools, healthcare providers and tech-enabled and other services.

“Earlier in my career, mentors of mine would advise that the work starts when a transaction closes. Never has that felt more apt than right now with our fund closing,” said Jim Momtazee, managing partner of Patient Square, which now has $5.9 billion in assets under management. “We have a tremendous amount of work in front of us, but without those that committed to our fund, there would not have been a beginning. We have deep gratitude for the opportunity and are working hard to reward that trust.”

PJT Park Hill served as the exclusive placement agent, subject to certain exclusions; Kirkland & Ellis served as legal counsel.

Patient Square has deployed approximately $3 billion in equity capital, including co-investments, since June 2021. Portfolio companies include Access Telecare, Apollo Therapeutics, Eargo, Enavate Sciences, Hanger Inc., Kriya Therapeutics, Radius Health, Resolve Biosciences, and Summit BHC.

The firm has been building up its team steadily as well, most recently naming former Neuberger Berman exec Kaveh Samie as senior advisor.

“We are thrilled to have strong support from wonderful partners around the globe. We feel fortunate, especially in light of such a challenging fundraising environment,” said Jake Cabala, partner and head of Fund Partnerships at Patient Square. “Our approach to creating value and serving patients really seemed to resonate.”

ShareTweetShareSendSend
Previous Post

MFA welcomes UK regulator’s recognition of short selling in ESG

Next Post

AW Top 10 reads for January

Related Posts

Hayfin taps head of DACH
Manager News

Hayfin taps head of DACH

Ohio SERS hires credit and buyout funds
Pensions

Ohio SERS hires credit and buyout funds

CLO market remains robust with new U.S. offerings
Private Credit

CLO market remains robust with new U.S. offerings

Schonfeld promotes regional heads for fundamental equity growth
Hedge Funds

Schonfeld promotes regional heads for fundamental equity growth

Ng to join Robert Wood Johnson Foundation as CIO
Endowments and Foundations

Ng to join Robert Wood Johnson Foundation as CIO

Next Post
AW Top 10 reads for January

AW Top 10 reads for January

Log In/Out

Lost your password?

Search the AW Archives

No Result
View All Result

Recent News

Hayfin taps head of DACH

Hayfin taps head of DACH

Ohio SERS hires credit and buyout funds

Ohio SERS hires credit and buyout funds

GAM bolsters systematic team

GAM bolsters systematic team

Napier Park harnesses the real asset opportunity

Napier Park harnesses the real asset opportunity

Be an Alts Insider

Sign up for your FREE daily alts news briefing

Subscribe

Subscribe to AW
Alternatives Watch

© 2019-2022, All Rights Reserved  |  BMV Digital

Navigate Site

  • Investor News
  • Private Equity
  • Private Credit
  • Hedge Funds
  • Real Estate/Infrastructure
  • Subscribe
  • Your Membership
  • Terms of Service
  • Privacy Policy

Follow Us

No Result
View All Result
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
  • Subscribe
  • Log In

© 2019-2022, All Rights Reserved  |  BMV Digital

Lost your password?

Be an alts insider

Start your days in the know with our free newsletter

No, I don't want to be an alts insider

Thank

You!

Follow us
on LinkedIn

This Website Uses Cookies
We use cookies on our website to provide necessary functions. By clicking “Accept”, you consent to the use of all strictly necessary cookies.
Do not sell my personal information.
Cookie Settings Accept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Save & Accept
Powered by CookieYes Logo